A new study by local urologist Robert I. Carey, MD, PhD, along with research colleagues from the Brian D. Jellison Cancer Institute and Sarasota Memorial Research Institute, has pinpointed a single gene which may help physicians identify higher risk prostate cancer patients and improve their treatment.